Genora Synthesis
Genora develops AI-guided genomic engineering platforms designed to accelerate precision medicine and next-generation gene therapies.
The Run
Introduction
OVERVIEW
Founder
Rachel Stein
Sector
Biotech
Stage
Seed
Status
Active Investments
Initial Investments
THE WHY
The Problem
Gene therapy development faces significant challenges due to unpredictable genetic interactions and lengthy experimental validation cycles, slowing the delivery of personalized treatments.
The Solution
Genora uses machine learning models trained on genomic datasets to predict gene-editing outcomes, enabling researchers to design safer and more precise therapies before clinical testing begins.
SNAPSHOT
The Presence
Where the Investment Located
LOCATION
Main Office
Cambridge, Massachusetts, United States
CONTACT
Website
